AI-Enhanced Bioactive 3D-Printed Scaffolds for Tissue Regeneration: Innovations in Healing and Functional Additives

Clicks: 1
ID: 312801
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #467 of 705 articles by views in Journal of Computing & Biomedical Informatics

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 705 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Bioactive 3D-printed scaffolds have revolutionized tissue engineering and regenerative medicine by enabling precise fabrication of biomimetic structures that promote cell adhesion, proliferation, and differentiation. However, significant challenges remain, particularly in optimizing scaffold composition, bioactive additive integration, and long-term stability for clinical applications. This review provides a systematic analysis of recent advancements in AI-driven bioactive scaffolds and their role in personalized regenerative medicine. A comparative evaluation of major 3D printing techniques—Fused Deposition Modeling (FDM), Stereolithography (SLA), Selective Laser Sintering (SLS), and Direct Metal Laser Sintering (DMLS)—is presented, focusing on resolution, material compatibility, and bioactive additive incorporation. Additionally, we analyze key bioactive agents (growth factors, nanoparticles, peptides, and natural polymers) and their effects on biocompatibility, mechanical strength, and therapeutic efficacy. AI-powered optimization techniques, including machine learning-based scaffold design, computational modeling, and predictive analytics, are emerging as transformative solutions for improving scaffold architecture, drug delivery systems, and patient-specific applications. Despite significant progress, major challenges persist, including standardization in scaffold fabrication, long-term in vivo validation, and regulatory approval hurdles. Addressing these scientific and regulatory challenges is essential for the successful clinical translation of bioactive scaffolds. This review highlights the need for interdisciplinary collaboration to advance AI-assisted scaffold engineering and establish personalized treatment strategies for next-generation regenerative medicine.
Reference Key
imported_1777056948_69ebbcb4213f6 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Adam Rafiq Jeraj, Zulekha Zameer
Journal Journal of Computing & Biomedical Informatics
Year 2025
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.